Transthyretin Amyloidosis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

By Type (ATTR-PN, ATTR-CM), By Therapy (Targeted Therapy (Onpattro, Inotersen, Vyndaqel/Vyndamax), Supportive Therapy, Pipeline Therapy), By Disease Type (Hereditary Transthyretin Amyloidosis (Polyneuropathy, Cardiomyopathy, Mixed Type), Wild Type Amyloidosis), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, By Competition

Published	Pages	Publisher	Report code
Nov 2023	179	TechSci Research	ASDR-642614

Published: Nov 2023 - Pages : 179 - Publisher : TechSci Research - Report code : ASDR-642614

1. Pfizer Inc.
2. Johnson & Johnson Services Inc.
3. Ionis Pharmaceuticals Inc.
4. Alnylam Pharmaceuticals Inc.
5. BridgeBio Pharma Inc.
6. Bristol-Myers Squibb Company.
7. Acrotech Biopharma.
8. AstraZeneca Plc.
9. SOM Biotech.

Transthyretin Amyloidosis Treatment Market Size, Share & Trends Analysis Report By Type (ATTR-PN, ATTR-CM), By Therapy, By Disease Type, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030

This report can be of interest as well:

Transthyretin Amyloidosis Treatment Market Size, Share & Trends Analysis Report By Type (ATTR-PN, ATTR-CM), By Therapy, ...

Published: September, 2022 | Report code: ASDR-609664

Mark your calendar:

Oligonucleotide Therapeutics and Delivery Conference 2024

09 September - 10 September, 2024
London, United Kingdom